Oracle’s, High-Stakes

Oracle’s High-Stakes AI Gamble Weighs on Investor Sentiment

02.01.2026 - 11:36:06

Oracle US68389X1054

Oracle Corporation has entered the 2026 fiscal year amid significant turbulence. The enterprise software leader is staking its future squarely on artificial intelligence infrastructure, but the ambitious pivot comes at a steep cost. Despite a record-breaking backlog of orders, substantial capital requirements and a negative cash flow position are fueling palpable market skepticism.

On the revenue side, Oracle's figures are undeniably strong. The company's remaining performance obligations (RPO) have skyrocketed to $523 billion, marking a staggering 438% increase year-over-year. This explosion in committed future revenue is primarily fueled by massive contracts with industry titans, including OpenAI and Nvidia.

Recent news of SoftBank's $41 billion investment in OpenAI reinforces the narrative that Oracle's Gen2 Cloud is in high demand. However, this success introduces a notable concentration risk. Oracle's near-term performance is now inextricably linked to the financial health and expansion pace of these key AI partners. Market observers point to an execution risk, as the company must front the capital for immense investments while the bulk of the profits are realized further down the line.

The Financial Strain of Expansion

The core pressure on Oracle's stock stems from a glaring divergence between growth and expenditure. While the company reported a 68% surge in cloud infrastructure revenue for its second quarter, the aggressive growth strategy is taking a measurable toll. To fund projects like the "Stargate" supercomputer and broader infrastructure build-out, Oracle has outlined capital expenditure (CapEx) plans approaching $50 billion for fiscal 2026.

Should investors sell immediately? Or is it worth buying Oracle?

This spending offensive has dramatically altered key financial metrics. Reports of a negative free cash flow ranging between $10 and $13 billion in the most recent quarter have unsettled more conservative investors. The focus on Wall Street has subtly shifted; it is no longer solely centered on pure growth potential but increasingly scrutinizes the efficiency and returns of these AI investments—what analysts often term "AI Economics."

Technical Outlook and the Path Forward

From a chart perspective, Oracle's shares are navigating a delicate technical area. The stock is currently testing a support zone between $193 and $194. A sustained break below this level could trigger additional selling pressure. Conversely, a decisive recovery above the $200 mark would be necessary to durably improve market sentiment.

The equity's performance for the remainder of the fiscal year hinges on one critical proof point: whether Oracle can demonstrate that its colossal investments are converting into recognized revenue faster than its debt obligations are mounting. The next pivotal moment for investors will be the quarterly earnings release scheduled for March 2026. This report is expected to provide concrete data on the company's cash burn rate and the development progress of the flagship "Stargate" project.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from January 2 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 2.

Oracle: Buy or sell? Read more here...

@ boerse-global.de | US68389X1054 ORACLE’S